Publications

Found 1 results
Filters: Author is B. Yacoubi Loueslati  [Clear All Filters]
2010
Y. B. Loueslati, Troudi, W., Cherni, L., Rhomdhane, K. B., and Mota-Vieira, L., Germline HVR-II mitochondrial polymorphisms associated with breast cancer in Tunisian women, vol. 9, pp. 1690-1700, 2010.
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, et al. (1999). Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 23: 147. http://dx.doi.org/10.1038/13779 PMid:10508508   Antognelli C, Del Buono C, Ludovini V, Gori S, et al. (2009). CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 9: 115. http://dx.doi.org/10.1186/1471-2407-9-115 PMid:19379515 PMCid:2680904   Asari M, Tan Y, Watanabe S, Shimizu K, et al. (2007). Effect of length variations at nucleotide positions 303-315 in human mitochondrial DNA on transcription termination. Biochem. Biophys. Res. Commun. 361: 641-644. http://dx.doi.org/10.1016/j.bbrc.2007.07.055 PMid:17673181   Booker LM, Habermacher GM, Jessie BC, Sun QC, et al. (2006). North American white mitochondrial haplogroups in prostate and renal cancer. J. Urol. 175: 468-472. http://dx.doi.org/10.1016/S0022-5347(05)00163-1   Bragoszewski P, Kupryjanczyk J, Bartnik E, Rachinger A, et al. (2008). Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer. BMC Cancer 8: 292. http://dx.doi.org/10.1186/1471-2407-8-292 PMid:18842121 PMCid:2571110   Canter JA, Kallianpur AR, Parl FF and Millikan RC (2005). Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65: 8028-8033. PMid:16140977   Carew JS and Huang P (2002). Mitochondrial defects in cancer. Mol. Cancer 1: 9. http://dx.doi.org/10.1186/1476-4598-1-9 PMid:12513701 PMCid:149412   Chan DC (2006). Mitochondria: dynamic organelles in disease, aging, and development. Cell 125: 1241-1252. http://dx.doi.org/10.1016/j.cell.2006.06.010 PMid:16814712   Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, et al. (2006). IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27: 758-765. http://dx.doi.org/10.1093/carcin/bgi294 PMid:16332723   Forster P, Harding R, Torroni A and Bandelt HJ (1996). Origin and evolution of Native American mtDNA variation: a reappraisal. Am. J. Hum. Genet. 59: 935-945. PMid:8808611 PMCid:1914796   Higuchi M (2007). Regulation of mitochondrial DNA content and cancer. Mitochondrion 7: 53-57. http://dx.doi.org/10.1016/j.mito.2006.12.001 PMid:17320491 PMCid:1868520   Jakupciak JP, Dakubo GD, Maragh S and Parr RL (2006). Analysis of potential cancer biomarkers in mitochondrial DNA. Curr. Opin. Mol. Ther. 8: 500-506. PMid:17243485   Kang D, Miyako K, Kai Y, Irie T, et al. (1997). In vivo determination of replication origins of human mitochondrial DNA by ligation-mediated polymerase chain reaction. J. Biol. Chem. 272: 15275-15279. http://dx.doi.org/10.1074/jbc.272.24.15275 PMid:9182553   Lee HC and Wei YH (2005). Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int. J. Biochem. Cell Biol. 37: 822-834. http://dx.doi.org/10.1016/j.biocel.2004.09.010 PMid:15694841   Lee HC and Wei YH (2009). Mitochondrial DNA instability and metabolic shift in human cancers. Int. J. Mol. Sci. 10: 674-701. http://dx.doi.org/10.3390/ijms10020674 PMid:19333428 PMCid:2660656   Miyazono F, Schneider PM, Metzger R, Warnecke-Eberz U, et al. (2002). Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene 21: 3780-3783. http://dx.doi.org/10.1038/sj.onc.1205532 PMid:12032845   Modica-Napolitano JS, Kulawiec M and Singh KK (2007). Mitochondria and human cancer. Curr. Mol. Med. 7: 121-131. http://dx.doi.org/10.2174/156652407779940495 PMid:17311537   Okobia MN, Bunker CH, Garte SJ, Zmuda JM, et al. (2008). Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC Cancer 8: 338. http://dx.doi.org/10.1186/1471-2407-8-338 PMid:19017403 PMCid:2613914   Okobia MN, Bunker CH, Garte SJ, Zmuda JM, et al. (2009). Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect. Agent. Cancer 4 (Suppl 1): S12. http://dx.doi.org/10.1186/1750-9378-4-S1-S12 PMid:19208203 PMCid:2638457   Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, et al. (2001). Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 61: 7623-7626. PMid:11606403   Parrella P, Seripa D, Matera MG, Rabitti C, et al. (2003). Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett. 190: 73-77. http://dx.doi.org/10.1016/S0304-3835(02)00578-5   Tan DJ, Bai RK and Wong LJ (2002). Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 62: 972-976. PMid:11861366   Troudi W, Uhrhammer N, Romdhane KB, Sibille C, et al. (2008). Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. Cancer Biomark. 4: 11-18. PMid:18334730   Wallace DC (2007). Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu. Rev. Biochem. 76: 781-821. http://dx.doi.org/10.1146/annurev.biochem.76.081205.150955 PMid:17506638   Wang X (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933. PMid:11711427   Xia P, An HX, Dang CX, Radpour R, et al. (2009). Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer 9: 454. http://dx.doi.org/10.1186/1471-2407-9-454 PMid:20025731 PMCid:2803198   Xu L, Hu Y, Chen B, Tang W, et al. (2006). Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int. J. Gynecol. Cancer 16: 1661-1667. http://dx.doi.org/10.1111/j.1525-1438.2006.00641.x PMid:16884381   Ye C, Gao YT, Wen W, Breyer JP, et al. (2008). Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women. Cancer Epidemiol. Biomarkers Prev. 17: 2117-2122. http://dx.doi.org/10.1158/1055-9965.EPI-07-2798 PMid:18708405 PMCid:2643086   Yu M, Zhou Y, Shi Y, Ning L, et al. (2007). Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB Life 59: 450-457. http://dx.doi.org/10.1080/15216540701509955 PMid:17654121   Yu M, Shi Y, Zhang F, Zhou Y, et al. (2008). Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J. Biomed. Sci. 15: 535-543. http://dx.doi.org/10.1007/s11373-007-9229-4 PMid:18157618   Zhou S, Kachhap S, Sun W, Wu G, et al. (2007). Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc. Natl. Acad. Sci U. S. A. 104: 7540-7545. http://dx.doi.org/10.1073/pnas.0610818104 PMid:17456604 PMCid:1863503   Zhu W, Qin W, Bradley P, Wessel A, et al. (2005). Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26: 145-152. http://dx.doi.org/10.1093/carcin/bgh282 PMid:15375011